Truvada Tablet, Film Coated
Product Images NDC 68071-2112

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Truvada (NDC 68071-2112). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

68071 2112 3

Truvada 200 mg/300 mg tablets label by NuCare Pharmaceuticals, Inc. The label states the product contains emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg. The packaging specifies 3 tablets, capsule-shaped blue tablets debossed with "GILEAD" on one side and "701" on the other. The label includes NDC 68071-2112-3 and warning to keep out of reach of children with storage instructions at controlled temperature 68-77°F.*

FDA Label Image

Chemical Structure (Truvada 01)

Chemical structure of emtricitabine, an active ingredient in Truvada. The diagram shows the molecular arrangement including nitrogen, oxygen, fluorine, sulfur atoms, with stereochemistry indicated.*

FDA Label Image

Chemical Structure (Truvada 02)

Chemical structure diagram of emtricitabine and tenofovir disoproxil fumarate, the active ingredients in Truvada. The image shows molecular structures with labeled atoms and bonds representing the components of the two compounds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.